• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mem Inst Oswaldo Cruz . SARS-CoV-2 variant N.9 identified in Rio de Janeiro, Brazil

tetano

Editor, Senior Moderator
Mem Inst Oswaldo Cruz


. 2021 Nov 8;116:e210166.
doi: 10.1590/0074-02760210166. eCollection 2021.
SARS-CoV-2 variant N.9 identified in Rio de Janeiro, Brazil


Luis Fernando Lopez Tort[SUP] 1 2 [/SUP], Ieda Pereira Ribeiro[SUP] 1 [/SUP], Lidiane Souza Raphael Menezes[SUP] 1 [/SUP], Alexandre Araújo Cunha Dos Santos[SUP] 1 [/SUP], Marta Pereira Santos[SUP] 1 [/SUP], Luana Damasceno[SUP] 3 [/SUP], Paola Cristina Resende Silva[SUP] 4 [/SUP], Marilda Agudo Mendonça Teixeira de Siqueira[SUP] 4 [/SUP], Patricia Brasil[SUP] 3 [/SUP], Myrna Cristina Bonaldo[SUP] 1 [/SUP]



Affiliations

Abstract

Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.33-derived lineage named N.9 was described recently in Brazil and it's considered a potential variant of interest (VOI) due to the presence of E484K substitution at the receptor-binding domain (RBD) of the Spike (S) protein.
Objective: To describe the first detection of variant N.9 in Rio de Janeiro State.
Methods: SARS-CoV-2 N.9 was confirmed by quantitative reverse transcription polymerase chain reaction (qRT-PCR), whole-genome sequencing and phylogenetic analysis.
Findings: Here, we report two SARS-CoV-2 N.9 lineage strains in Rio de Janeiro. One of them had only the E484K substitution of the six N.9 lineage-defining mutations. Other three strains pre-defined as N.9 have the same genomic profile. These four strains are grouped within the B.1.1.33 lineage and basal to the N.9 lineage in our phylogenetic analysis, and we call them "N.9-like/B.1.1.33 + E484K".
Main conclusions: The phylogenetic analysis shows four independent introductions of N.9 in the state of Rio de Janeiro in October and December 2020, January and March 2021. SARS-CoV-2 N.9 dissemination in the Rio de Janeiro could have been limited by the emergence and dominance of other variants, mainly by the lineage P.2 VOI Zeta that emerged in the same period and co-circulated with N.9, as observed in the neighboring State of São Paulo.
 
Back
Top Bottom